Last, Gak-KO mice had increased calpain-1/-2 activities in the podocytes, glomeruli, and urine (Figure 4, E–G), which mirrors similar findings in human FSGS patients (13, 15). This evidence concerns the gene GAK and focal segmental glomerulosclerosis.